Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia

Retina

Volumn 28, Issue 6, 2008, Pages 808-816

  Helb, Hans Martin ^a   Charbel Issa, Peter ^a   Van Der Veen, Rob L P ^b   Berendschot, Tos T J M ^b   Scholl, Hendrik P N ^a   Holz, Frank G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Confocal scanning laser ophthalmoscope; Heterochromatic flicker photometry; Idiopathic juxtafoveolar telangiectasia; Idiopathic macular telangiectasia; Idiopathic parafoveolar telangiectasia; Macular pigment; Retinal telangiectasia

Indexed keywords

PIGMENT; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BIOMICROSCOPY; CLINICAL ARTICLE; EYE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMAGE ANALYSIS; MALE; MORPHOLOGICAL TRAIT; OPHTHALMOSCOPE; OPTICAL COHERENCE TOMOGRAPHY; PHOTOGRAPHY; PHOTOMETRY; PIGMENTATION; RECORDING; TELANGIECTASIA; TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA; VISION TEST; VISUAL ACUITY; ACOUSTIC MICROSCOPY; CLASSIFICATION; METABOLISM; MIDDLE AGED; OPHTHALMOSCOPY; PATHOLOGY; RETINA BLOOD VESSEL; RETINA DISEASE;

AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LUTEIN; MALE; MICROSCOPY, ACOUSTIC; MIDDLE AGED; OPHTHALMOSCOPY; RETINAL DISEASES; RETINAL PIGMENTS; RETINAL VESSELS; TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; XANTHOPHYLLS;

EID: 47749091309     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31816d81aa     Document Type: Article

References (36)

1. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100:1536-1546.
2. Yannuzzi LA, Bardal AM, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124:450-460.
3. Charbel Issa P, Scholl HPN, Helb HM, Holz FG. Idiopathic macular telangiectasia. In: Holz FG, Spaide RF, eds. Medical Retina. Berlin, Heidelberg, New York: Springer; 2007:183-197.
4. Charbel Issa P, Helb HM, Rohrschneider K, et al. Microperimetric assessment of patients with type 2 macular telangiectasia. Invest Ophthalmol Vis Sci 2007;48:3788-3795.
5. Charbel Issa P, Holz FG, Scholl HPN. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007;114:1736-1742.
6. Charbel Issa P, Scholl HPN, Holz FG. Intravitreal bevacizumab for the treatment of type 2 idiopathic macular telangiectasis. Retinal Cases & Brief Reports 2007;1:79-81.
7. Delori FC, Goger DG, Hammond BR, et al. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 2001;18:1212-1230.
8. Wolf S. Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol 2006; 244:1562-1564.
9. Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2003;241:1006-1012.
10. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 2006;244:1565-1574.
11. Wüstemeyer H, Moessner A, Jahn C, Wolf S. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 2003;241:647-651.
12. Berendschot TT, van Norren D. Objective determination of the macular pigment optical density using fundus reflectance spectroscopy. Arch Biochem Biophys 2004;430:149-155.
13. Delori FC. Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 2004;430:156-162.
14. Ossewaarde-Van NJ, van Den Biesen PR, van de Kraats J, et al. Comparison of fluorescence of sodium fluorescein in retinal angiography with measurements in vitro. J Biomed Opt 2002;7:190-198.
15. DeMarco P, Pokorny J, Smith VC. Full-spectrum cone sensitivity functions for X-chromosome-linked anomalous trichromats. J Opt Soc Am A Opt Image Sci Vis 1992;9: 1465-1476.
16. Berendschot TT, van der Veen RL, Carden D, et al. Desktop macular pigment optical. Density measurement: a new approach based on heterochromatic flicker photometry. Invest Ophthalmol Vis Sci 2007;48:2138.
17. Charbel Issa P, Scholl HPN, Helb HM, Holz FG. Idiopathic macular telangiectasia. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin, Heidelberg, New York: Springer; 2007:199- 205.
18. Charbel Issa P, Berendschot TT, Staurenghi G, et al. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2008;49:1172-1177.
19. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006;124: 1038-1045.
20. Berendschot TT, van Norren D. On the age dependency of the macular pigment optical density. Exp Eye Res 2005;81:602- 609.
21. Bone RA, Landrum JT. Heterochromatic flicker photometry. Arch Biochem Biophys 2004;430:137-142.
22. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 1987; 27:257-268.
23. Bone RA, Landrum JT, Gibert JC. Macular pigment and the edge hypothesis of flicker photometry. Vision Res 2004;44: 3045-3051.
24. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006;124: 1038-1045.
25. Bone RA, Landrum JT, Cains A. Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 1992; 32:105-110.
26. Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997;64:211-218.
27. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29:850-855.
28. Bhosale P, Larson AJ, Frederick JM, et al. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 2004;279:49447-49454.
29. Yemelyanov AY, Katz NB, Bernstein PS. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 2001;72:381-392.
30. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 1997;38:167-175.
31. Berendschot TT, van Norren D. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci 2006;47:709- 714.
32. Delori FC, Goger DG, Keilhauer C, et al. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A Opt Image Sci Vis 2006;23:521- 538.
33. Snodderly DM, Brown PK, Delori FC, Auran JD. The mac-ular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984;25:660-673.
34. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 2006; 82:828-839.
35. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:1981-1989.
36. Koh HH, Murray IJ, Nolan D, et al. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004; 79:21-27.